I-Corps: Translation Potential of a Precision Biomarker and Therapeutics for Advanced Canc — NSF Award to University of Maryland E
This I-Corps project focuses on the development of a technology for cancer diagnosis and therapy. Cancer remains the second leading cause of deaths in the United States. According to the American Cancer Society, an estimated 618,120 people are projected to die from cancer in in 2025. There is an urgent need for more ac
| Award title | I-Corps: Translation Potential of a Precision Biomarker and Therapeutics for Advanced Canc |
|---|---|
| Award ID | 2450154 |
| Awardee | University of Maryland Eastern Shore |
| City | PRINCESS ANNE |
| State | MD |
| Amount obligated | $50,000 |
| Principal investigator | Bi-Dar Wang |
| Program | I-Corps |
| Start date | 07/01/2025 |
| Abstract | This I-Corps project focuses on the development of a technology for cancer diagnosis and therapy. Cancer remains the second leading cause of deaths in the United States. According to the American Cancer Society, an estimated 618,120 people are projected to die from cancer in in 2025. There is an urgent need for more accurate diagnostic tools and more effective therapies for this devastating disease. This technology aims to help physicians accurately detect cancer diseases and to make informed tr |
| Source | NSF Awards |
$799/mo
Try NSFGrants →